I am a breastfeeding mother and i want to know if it is safe to use 17alpha-Ethinylestradiol? Is 17alpha-Ethinylestradiol safe for nursing mother and child? Does 17alpha-Ethinylestradiol extracts into breast milk? Does 17alpha-Ethinylestradiol has any long term or short term side effects on infants? Can 17alpha-Ethinylestradiol influence milk supply or can 17alpha-Ethinylestradiol decrease milk supply in lactating mothers?
- DrLact safety Score for 17alpha-Ethinylestradiol is 3 out of 8 which is considered Low Risk as per our analyses.
- A safety Score of 3 indicates that usage of 17alpha-Ethinylestradiol may cause some minor side effects in breastfed baby.
- Our study of different scientific research indicates that 17alpha-Ethinylestradiol may cause moderate to no side effects in lactating mother.
- Most of scientific studies and research papers declaring usage of 17alpha-Ethinylestradiol low risk in breastfeeding are based on normal dosage and may not hold true for higher dosage.
- While using 17alpha-Ethinylestradiol We suggest monitoring child for possible reactions. It is also important to understand that side effects vary largely based on age of breastfed child and time of medication in addition to dosage.
- Score calculated using the DrLact safety Version 1.2 model, this score ranges from 0 to 8 and measures overall safety of drug in lactation. Scores are primarily calculated using publicly available case studies, research papers, other scientific journals and publically available data.
Synthetic estrogen that has a similar action as estradiol. Used in combination with progestogens for contraception. Ethinylestradiol is excreted in small or no amount into breast milk.There is evidence (albeit inconsistent) that estrogen-containing pills may decrease milk production, especially during the first few weeks postpartum with a daily dose above 30 micrograms of 17alpha-Ethinylestradiol.It may reduce the protein content of the milk.No problems have been observed in infants whose mothers were treated, except some cases of transient gynecomastia in infants whose mothers were receiving a higher dose than usual. During lactation progestin-only drugs are preferred or in combination with estrogen for birth control, but whatever, the ones with the lower doses of estrogen should be used.For the first 6 weeks postpartum, non-hormonal methods are of choise.
This record contains information specific to 17alpha-Ethinylestradiol used alone. Users with an interest in an oral contraceptive should consult the record entitled, "Contraceptives, Oral, Combined."There is little information available on the use of 17alpha-Ethinylestradiol alone during breastfeeding. Levels in milk appear to be low. Based on studies on oral contraceptives that contain 17alpha-Ethinylestradiol, immediate side effects such as breast enlargement appear to occur rarely. It seems likely that doses of 30 mcg daily or greater can suppress lactation. The magnitude of the effect on lactation likely depends on the dose and the time of introduction postpartum, but data are not adequate to accurately define these doses and times.
Published information was not found as of the revision date on the effects of 17alpha-Ethinylestradiol alone on breastfed infants. However, case reports exist of breast enlargement in the infants of mothers taking combination oral contraceptives that contained 17alpha-Ethinylestradiol or its prodrug, mestranol.[1][3][4][5]
Published information was not found as of the revision date on the effects of 17alpha-Ethinylestradiol on milk production. However, numerous studies on combination contraceptives containing 17alpha-Ethinylestradiol or its prodrug mestranol indicate that doses of 30 mcg daily or greater might interfere with lactation.[6][7][8][9][10][11] One study that used a contraceptive containing 10 mcg of 17alpha-Ethinylestradiol found no effect on lactation.[12]A retrospective cohort study compared 371 women who received high-dose estrogen (either 3 mg of diethylstilbestrol or 150 mcg of 17alpha-Ethinylestradiol daily)during adolescence for adult height reduction to 409 women who did not receive estrogen. No difference in breastfeeding duration was found between the two groups, indicating that high-dose estrogen during adolescence has no effect on later breastfeeding.[13]
Disclaimer:
Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. We do not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.